21307202_460x337.jpg

Kardiologie / Angiologie

Sie befinden sich hier:

Kardiologie / Angiologie

Autor Titel/Link Jahr Journal
deFilippi and Herzog Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease. 2017 Clinical chemistry
Apple et al. Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care. 2017 Clinical chemistry
Chen and Burnett Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease. 2017 Clinical chemistry
Cullen et al. Early Rule-Out and Rule-In Strategies for Myocardial Infarction. 2017 Clinical chemistry
Dhingra and Vasan Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. 2017 Trends in cardiovascular medicine
Di Nisio et al. Deep vein thrombosis and pulmonary embolism. 2017 Lancet (London, England)
Eggers and Lindahl Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome. 2017 Clinical chemistry
Everett Cardiac troponin as a novel tool for cardiovascular risk prediction in ambulatory populations. 2017 Trends in cardiovascular medicine
Giannitsis and Katus Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism. 2017 Clinical chemistry
Hazarika and Annex Biomarkers and Genetics in Peripheral Artery Disease. 2017 Clinical chemistry
McGarrah et al. A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality. 2017 Clinical chemistry
Miller and Shyy Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation. 2017 Trends in endocrinology and metabolism: TEM
Omland and White State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease. 2017 Clinical chemistry
Sandoval and Thygesen Myocardial Infarction Type 2 and Myocardial Injury. 2017 Clinical chemistry
Tricoci Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention. 2017 Clinical chemistry
Vasile and Jaffe Natriuretic Peptides and Analytical Barriers. 2017 Clinical chemistry
Walsh and Cook Issues and Challenges in Diagnostic Sequencing for Inherited Cardiac Conditions. 2017 Clinical chemistry
Wollert et al. Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease. 2017 Clinical chemistry
Akyol et al. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders. 2016 Clinica chimica acta; international journal of clinical chemistry
Beneke et al. Differenzierung thrombotischer Mikroangiopathien 2016 Der Nephrologe
Bindu et al. Role of Sirtuins in Regulating Pathophysiology of the Heart. 2016 Trends in endocrinology and metabolism: TEM
Cahill and Prendergast Infective endocarditis. 2016 Lancet
Cogswell et al. Dietary Sodium and Cardiovascular Disease Risk – Measurement Matters. 2016 The New England journal of medicine
Evstatiev Eisenmangel, Thrombozytose und Thromboembolie 2016 Wiener Medizinische Wochenschrift
Gao et al. Functional regulatory roles of microRNAs in atherosclerosis. 2016 Clinica chimica acta; international journal of clinical chemistry
Gladwin Cardiovascular complications and risk of death in sickle-cell disease. 2016 Lancet (London, England)
Grundy Metabolic syndrome update. 2016 Trends Cardiovasc Med
Hai and Zuo Aberrant DNA methylation in the pathogenesis of atherosclerosis. 2016 Clin Chim Acta
Horvatits et al. Hepatokardiale Wechselwirkungen 2016 Medizinische Klinik - Intensivmedizin und Notfallmedizin
Janssens and Joannidis Akute kardiorenale Syndrome 2016 Medizinische Klinik - Intensivmedizin und Notfallmedizin
Jin et al. Apoprotein C-III: A review of its clinical implications. 2016 Clinica chimica acta; international journal of clinical chemistry
Koskinas et al. Regression of coronary atherosclerosis: Current evidence and future perspectives. 2016 Trends Cardiovasc Med
Kotani et al. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions. 2016 Critical reviews in clinical laboratory sciences
Laux et al. A medical-toxicological view of tattooing. 2016 Lancet
Lazo et al. Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study. 2016 Clinical chemistry
Manrai et al. Genetic Misdiagnoses and the Potential for Health Disparities. 2016 The New England journal of medicine
Mizamtsidi et al. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? 2016 European journal of clinical investigation
Mulay and Anders Crystallopathies. 2016 N Engl J Med
Myles et al. Stopping vs. Continuing Aspirin before Coronary Artery Surgery. 2016 N Engl J Med
Nioi et al. Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. 2016 N Engl J Med
Nordestgaard et al. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. 2016 Clinical chemistry
O'Neill et al. Blood-Based Biomarkers for Metabolic Syndrome. 2016 Trends Endocrinol Metab
O'Shea et al. Hypertension: The role of biochemistry in the diagnosis and management. 2016 Clinica chimica acta; international journal of clinical chemistry
Park-Windhol and D'Amore Disorders of Vascular Permeability. 2016 Annu Rev Pathol
Pfeffer and McMurray Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension. 2016 The New England journal of medicine
Pownall and Gotto New Insights into the High-Density Lipoprotein Dilemma. 2016 Trends Endocrinol Metab
Santos et al. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. 2016 The lancet. Diabetes & endocrinology
Schefold et al. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. 2016 Nature reviews. Nephrology
Stancel et al. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. 2016 Clin Chem
Strotmann and Wolpert Antikoagulation und perioperatives Bridging 2016 Der Kardiologe
Tybjærg-Hansen The Sialylation Pathway and Coronary Artery Disease. 2016 N Engl J Med
Wang Vitamin D and Cardiovascular Disease. 2016 Annu Rev Med
Wanner et al. The heart and vascular system in dialysis. 2016 Lancet (London, England)
Wechalekar et al. Systemic amyloidosis. 2016 Lancet (London, England)
Zhong et al. Sortilin: A novel regulator in lipid metabolism and atherogenesis. 2016 Clinica chimica acta; international journal of clinical chemistry
Anwar et al. Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs. 2015 Trends Cardiovasc Med
Buglioni and Burnett Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators. 2015 Clin Chim Acta
Clerico et al. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 2015 Clin Chim Acta
Cozzolino New endocrine biomarkers and cardiovascular disease: is it time for routinely screening? 2015 Clin Chem Lab Med
Dokmanovic and Wu Monitoring Trastuzumab Resistance and Cardiotoxicity: A Tale of Personalized Medicine. 2015 Advances in Clinical Chemistry
Dzeshka and Lip Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now? 2015 Trends Cardiovasc Med
Eren et al. HDL functionality and crystal-based sterile inflammation in atherosclerosis. 2015 Clin Chim Acta
Evrard et al. Vascular calcification: from pathophysiology to biomarkers. 2015 Clin Chim Acta
Fernandes and Valdes Cardiovascular disease and osteoarthritis: common pathways and patient outcomes. 2015 Eur J Clin Invest
Gulati and Merz New cholesterol guidelines and primary prevention in women. 2015 Trends Cardiovasc Med
Herder et al. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications. 2015 Trends Endocrinol Metab
Kobayashi and Mabuchi Lipoprotein lipase and atherosclerosis. 2015 Annals of clinical biochemistry
Kutkut et al. Lymphatic vessels: an emerging actor in atherosclerotic plaque development. 2015 Eur J Clin Invest
Lavandero et al. Autophagy in cardiovascular biology. 2015 J Clin Invest
Luo et al. Cystatin C and cardiovascular or all-cause mortality risk in the general population: A meta-analysis. 2015 Clin Chim Acta
Ma and Li SIRT1: role in cardiovascular biology. 2015 Clin Chim Acta
Mahajan et al. Impact of obesity on cardiac metabolism, fibrosis, and function. 2015 Trends Cardiovasc Med
Manousopoulou et al. Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. 2015 Eur J Clin Invest
Massy and Drüeke Magnesium and cardiovascular complications of chronic kidney disease. 2015 Nat Rev Nephrol
Matsushita et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. 2015 Lancet Diabetes Endocrinol
Mehta et al. Ischemic heart disease in women: a focus on risk factors. 2015 Trends Cardiovasc Med
Min and Chan The biology of circulating microRNAs in cardiovascular disease. 2015 Eur J Clin Invest
O'Hare et al. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity. 2015 Expert Rev Cardiovasc Ther
Opie Present status of statin therapy. 2015 Trends Cardiovasc Med
Pouleur Which biomarkers do clinicians need for diagnosis and management of heart failure with reduced ejection fraction? 2015 Clin Chim Acta
Poulter et al. Hypertension. 2015 Lancet
Rabelink and de Zeeuw The glycocalyx – linking albuminuria with renal and cardiovascular disease. 2015 Nat Rev Nephrol
Roberts A genetic basis for coronary artery disease. 2015 Trends Cardiovasc Med
Rungoe et al. Inflammatory bowel disease and risk of coronary heart disease. 2015 Trends Cardiovasc Med
Saleheen et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. 2015 Lancet Diabetes Endocrinol
Salerni et al. The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens. 2015 Eur J Clin Invest
Sedaghat-Hamedani et al. Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury – a metaanalysis of 45 studies. 2015 Clin Chem
da Silva et al. Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. 2015 Eur J Clin Invest
Stankowski et al. Cardiovascular consequences of cocaine use. 2015 Trends Cardiovasc Med
van Tienhoven-Wind and Dullaart Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. 2015 Eur J Clin Invest
Timmis Acute coronary syndromes. 2015 BMJ (Clinical research ed.)
Torre and Jarolim Cardiac troponin assays in the management of heart failure. 2015 Clin Chim Acta
Xiong et al. Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation. 2015 Expert Opin Drug Metab Toxicol